Influence of different cellular environments on [3H]DASB radioligand binding

Synapse

Volumn 66, Issue 12, 2012, Pages 1035-1039

  Quelch, D R ^a   Parker, C A ^a   Nutt, D J ^a   Tyacke, R J ^a   Erritzoe, D ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

3H DASB; Internalization; Ionic conditions; PET; Serotonin transporter

Indexed keywords

CLATHRIN; DASB H 3; RADIOLIGAND; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; DOWN REGULATION; DRUG RECEPTOR BINDING; ENDOCYTOSIS; INTRACELLULAR SPACE; ISOTOPE LABELING; LIGAND BINDING; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOACTIVITY; RAT; SIGNAL TRANSDUCTION; STRIATE CORTEX;

ANIMALS; BENZYLAMINES; CELL MEMBRANE; HYDROGEN-ION CONCENTRATION; INTRACELLULAR MEMBRANES; LIGANDS; MALE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TRITIUM;

EID: 84867653820     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21605     Document Type: Article

References (52)

1. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walker P. 2002. Molecular biology if the cell. New York: Garland Science.
2. Androutsellis-Theotokis A, Ghassemi F, Rudnick G. 2001. A conformationally sensitive residue on the cytoplasmic surface of serotonin transporter. J Biol Chem 276: 45933-45938.
3. Benmansour S, Cecchi M, Morilak DA, Gerhardt GA, Javors MA, Gould GG, Frazer A. 1999. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level. J Neurosci 19: 10494-10501.
4. Benmansour S, Owens WA, Cecci M, Morilak DA, Frazer, A. 2002. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter. J Neurosci 22: 6766-6772.
5. Brinley FJJr. 1980. Regulation of intracellular calcium in squid axons. Fed Proc 39: 2778-2782.
6. Buchert R, Thomasius R, Wilke F, Petersen K, Nebeling B, Obrocki J, Schulze O, Schmidt U, Clausen M. 2004. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters. Am J Psychiatry 161: 1181-1189.
7. Capela JP, Carmo H, Remiao F, Bastos ML, Meisel A, Carvalho F. 2009. Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: An overview. Mol Neurobiol 39: 210-271.
8. Chanrion B, Mannoury La Cour C, Bertaso F, Lerner-Natoli M, Freissmuth M, Millan M, Bockaert J, Marin P. 2007. Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci USA 104: 8119-8124.
9. Christensen KA, Myers JT, Swanson JA. 2002. pH-dependent regulation of lysosomal calcium in macrophages. J Cell Sci 115(Part 3): 599-607.
10. Coull MA, Lowther S, Katona CL, Horton RW. 2000. Altered brain protein kinase C in depression: A post-mortem study. Eur Neuropsychopharmacol 10: 283-288.
11. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN. 2001. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77: 916-928.
12. Erritzoe D, Frokjaer VG, Holst KK, Christoffersen M, Johansen SS, Svarer C, Madsen J, Rasmussen PM, Ramsoy T, Jernigan TL, Knudsen GM. 2011. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3, 4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users. Arch Gen Psychiatry 68: 562-576.
13. Faundez V, Hartzell HC. 2004. Intracellular chloride channels: determinants of function in the endosomal pathway. Sci STKE 2004: re8.
14. Gekle M, Drumm K, Mildenberger S, Freudinger R, Gassner B, Silbernagl S. 1999. Inhibition of Na+-H+ exchange impairs receptor-mediated albumin endocytosis in renal proximal tubule-derived epithelial cells from opossum. J Physiol 520(Part 3): 709-721.
15. Gerasimenko JV, Tepikin AV, Petersen OH, Gerasimenko OV. 1998. Calcium uptake via endocytosis with rapid release from acidifying endosomes. Curr Biol 8: 1335-1338.
16. Grabe M, Oster G. 2001. Regulation of organelle acidity. J Gen Physiol 117: 329-344.
17. Guo N, Guo W, Kralikova M, Jiang M, Schieren I, Narendran R, Slifstein M, Abi-Dargham A, Laruelle M, Javitch JA, Rayport S. 2010. Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers. Neuropsychopharmacology 35: 806-817.
18. Hrdina PD, Foy B, Hepner A, Summers RJ. 1990. Antidepressant binding sites in brain: Autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter. J Pharmacol Exp Ther 252: 410-418.
19. Humphreys CJ, Wall SC, Rudnick G. 1994. Ligand binding to the serotonin transporter: equilibria, kinetics, and ion dependence. Biochemistry 33: 9118-9125.
20. Hummerich R, Reischl G, Ehrlichmann W, Machulla HJ, Heinz S, Schloss P. 2004. DASB -in vitro binding characteristics on human recombinant monoamine transporters with regard to its potential as positron emission tomography (PET) tracer. J Neurochem 90: 1218-1226.
21. Kim KM, Valenzano KJ, Robinson SR, Yao WD, Barak LS, Caron MG. 2001. Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins. J Biol Chem 276: 37409-37414.
22. Kittler K, Lau T, Schloss P. 2010. Antagonists and substrates differentially regulate serotonin transporter cell surface expression in serotonergic neurons. Eur J Pharmacol 629: 63-67.
23. Kivell B, Day D, Bosch P, Schenk S, Miller J. 2010. MDMA causes a redistribution of serotonin transporter from the cell surface to the intracellular compartment by a mechanism independent of phospho-p38-mitogen activated protein kinase activation. Neuroscience 168: 82-95.
24. Kramer K, Poblete C, Azmitia E. 1995. 3, 4-Methylenedioxymethamphetamine ('Ecstasy') promotes the translocation of protein kinase C (PKC): requirement of viable serotonin nerve terminals. Brain Res 680: 1-8.
25. Kramer K, Poblete C, Azmitia E. 1998. Characterization of the translocation of protein kinase C (PKC( by 3, 4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter )SERT(Neuropsychopharmacology 19: 265-77.
26. Laruelle M. 2000. Imaging synaptic neurotransmission with in vivo binding competition techniques: A critical review. J Cerebral Blood Flow Metab 20: 423-451.
27. Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y, Kosaka J, Arakawa R, Fujimura Y, Ota M, Takano A, Fukui K, Nakayama K, Suhara T. 2010. Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: A [11C]DASB PET study. NeuroImage 49: 121-126.
28. McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA. 2005. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology 30: 1741-1750.
29. Miller JM, Kinnally EL, Ogden RT, Oquendo MA, Mann JJ, Parsey RV. 2009. Reported childhood abuse is associated with low serotonin transporter binding in vivo in major depressive disorder. Synapse 63: 565-573.
30. Murphy JF, Powers S, Cantor CR. 1984. Endosome pH measured in single cells by dual fluorescence flow cytometry: Rapid acidification of insulin to pH 6.0. J Cell Biol 98: 1757-1762.
31. Paterson LM, Tyacke RJ, Nutt DJ, Knudsen GM. 2010. Measuring endogenous 5-HT release by emission tomography: Promises and pitfalls. J Cerebral Blood Flow Metab 30: 1682-1706.
32. Pickel VM, Chan J. 1999. Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens. J Neurosci 19: 7356-7366.
33. Praschak-Rieder N, Wilson AA, Hussey D, Carella A, Wei C, Ginovart N, Schwarz MJ, Zach J, Houle S, Meyer JH. 2005. Effects of tryptophan depletion on the serotonin transporter in healthy humans. Biol Psychiatry 58: 825-830.
34. Qi X, Lin W, Li J, Pan Y, Wang W. 2006. The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behav Brain Res 175: 233-240.
35. Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD. 1997. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neurosci 17: 45-57.
36. Quelch DR, Nutt DJ, Parker CA, Tyacke RJ. 2011a. Effects of cellular environments on PET radioligand binding-An application to dopamine and opioid receptor imaging. J Psychopharmacol 25( Suppl 8): A60.
37. Quelch DR, Tyacke RJ, Nutt DJ, Parker CA. 2011b. P.1.007 Assessment of cellular environments on radioligand binding-An application to opioid receptor PET imaging. Eur Neuropsychopharmacol 21 ( Suppl 1): S7-S8.
38. Ramamoorthy S, Blakely RD. 1999. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Science 285: 763-766.
39. Reimold M, Batra A, Knobel A, Smolka MN, Zimmer A, Mann K, Solbach C, Reischl G, Schwarzler F, Grunder G, Machulla HJ, Bares R, Heinz A. 2008. Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: A [11C]DASB PET study. Mol Psychiatry 13: 606-613, 557.
40. Reneman L, Booij J, de Bruin K, Reitsma JB, de Wolff FA, Gunning WB, den Heeten GJ, van den Brink W. 2001. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons. Lancet 358: 1864-1869.
41. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy S. 2005. A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: Evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci 25: 29-41.
42. Somjen GG. 2004. Ions in the brain, normal function, seizures and stroke. USA: Oxford University Press.
43. Sur C, Betz H, Schloss P. 1996. Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 73: 217-231.
44. Taliaferro P, Ramos J, Lopez-Costa J, Lopez M, Saavedra P, Brusco A. 2001. Increased nitric oxide synthase activity in a model of serotonin depletion. Brain Res Bull 54: 199-205.
45. Talbot PS, Frankle WG, Hwang DR, Huang Y, Suckow RF, Slifstein M, Abi-Dargham A, Laruelle M. 2005. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans. Synapse 55: 164-175.
46. Tibbles LA, Woodgett JR. 1999. The stress-activated protein kinase pathways. Cell Mol Life Sci 55: 1230-1254.
47. Wall S, Innis R, Rudnick G. 1992. Binding of the cocaine analog 2 beta-carbomethoxy-3 beta-)4-[125I]iodophenyl)tropane to serotonin and dopamine transporters: different ionic requirements for substrate and 2 beta-carbomethoxy-3 beta-(4-[125I]iodophenyl)tropane binding. Mol Pharm 43: 264-270.
48. Wang X, Baumann MH, Xu H, Rothman RB. 2004. 3, 4-Methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein. Synapse 53: 240-248.
49. Wang X, Baumann MH, Xu H, Morales M, Rothman RB. 2005. (+/-) -3, 4-Methylenedioxymethamphetamine administration to rats does not decrease levels of the serotonin transporter protein or alter its distribution between endosomes and the plasma membrane. J Pharmacol Exp Ther 314: 1002-1012.
50. Wilson AA, Ginovart N, Schmidt M, Meyer JH, Threlkeld PG, Houle S. 2000. Novel radiotracers for imaging the serotonin transporter by positron emission tomography: Synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines. J Med Chem 43: 3103-3110.
51. 1DAR. J Psychopharmacol 23_3.
52. Yu A, Yang J, Pawlyk AC, Tejani-Butt SM. 1995. Acute depletion of serotonin down-regulates serotonin transporter mRNA in raphe neurons. Brain Res 688: 209-212.